"Fantastic" clinical uptake driving revenue.
Replace the asterisks with aus biz (no space).
https://******.com.au/media/fantastic-clinical-uptake-driving-revenue?videoId=36704
Key points:
- Orthocell's (ASX: OCC) increasing revenue is hugely driven by the sale of their two approved products
- A partnership with Buy Horizons has allowed Orthocell to expand internationally
- The US market represents a huge opportunity for Orthocell, with plans already in place for expansion
Media thread, page-562
-
- There are more pages in this discussion • 166 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
62.5¢ |
Change
0.010(1.63%) |
Mkt cap ! $148.2M | |||
| Open | High | Low | Value | Volume |
| 61.5¢ | 63.0¢ | 61.5¢ | $189.6K | 303.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 37575 | 62.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 62.5¢ | 41311 | 6 |
View Market Depth
| Last trade - 13.07pm 05/11/2024 (20 minute delay) ? |
| OCC (ASX) Chart |